Loading...
About this Episode
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com.
See omnystudio.com/listener for privacy information.
Hosts & Guests
No transcript available for this episode.
